Ocular Therapeutix, Inc. (OCUL) Stock Total Returns
Growth of $10,000 chart
2021-04-21 to 2026-04-21 to
$
%
%
Loading chart…
Investment Performance
Final Value
$6,095
Total Return
-39.05%
CAGR
-9.43%
Dividends
$0.00
Yield on Cost
0.00%
Rolling Returns
1-Month (21 Trading Days)
| Average | +1.66% |
| Median | -2.89% |
| Best | +145.89% |
| Worst | -54.35% |
| % of Windows Positive | 45.3% |
1-Year (252 Trading Days)
| Average | +26.80% |
| Median | +16.75% |
| Best | +403.56% |
| Worst | -80.58% |
| % of Windows Positive | 60.5% |
3-Year (756 Trading Days)
| Average | +81.78% |
| Median | +56.06% |
| Best | +442.42% |
| Worst | -73.80% |
| % of Windows Positive | 74.7% |
Risk Metrics
| Maximum Drawdown | -89.14% |
| Average Drawdown | -61.09% |
| Drawdown Duration | 1248 Trading Days (Unrecovered) |
| Sortino Ratio | 0.41 |
| Calmar Ratio | -0.11 |
| CVaR (5%) | -9.92% |
Yearly Returns
| Year | Percentage | Abs. Return | Dividends | Taxes | Trans. Costs |
|---|---|---|---|---|---|
| 2026 partial | -23.23% (-58.10% ann.) | $2322.90 | $0.00 | $0.00 | $0.00 |
| 2025 | +42.15% | +$4215.45 | $0.00 | $0.00 | $0.00 |
| 2024 | +91.48% | +$9147.96 | $0.00 | $0.00 | $0.00 |
| 2023 | +58.72% | +$5871.93 | $0.00 | $0.00 | $0.00 |
| 2022 | -59.68% | $5968.44 | $0.00 | $0.00 | $0.00 |
| 2021 | -66.33% | $6632.85 | $0.00 | $0.00 | $0.00 |
| 2020 | +424.05% | +$42405.12 | $0.00 | $0.00 | $0.00 |
| 2019 | -0.75% | $75.40 | $0.00 | $0.00 | $0.00 |
| 2018 | -10.56% | $1056.17 | $0.00 | $0.00 | $0.00 |
| 2017 | -46.83% | $4683.39 | $0.00 | $0.00 | $0.00 |
| 2016 | -10.67% | $1067.24 | $0.00 | $0.00 | $0.00 |
| 2015 | -60.16% | $6016.15 | $0.00 | $0.00 | $0.00 |
| 2014 partial | +78.86% (+280.24% ann.) | +$7885.93 | $0.00 | $0.00 | $0.00 |
Market Regimes
about| Regime | Period | Percentage | Annual | Abs. Return | Dividends | Taxes | Trans. Costs |
|---|---|---|---|---|---|---|---|
| Secular stagnation / QE / low inflation / duration bull partial | July 25, 2014 – February 19, 2020 | -59.77% | -15.08% | $5977.19 | $0.00 | $0.00 | $0.00 |
| Pandemic shock / liquidity crash | February 20, 2020 – March 23, 2020 | -10.07% | -70.24% | $1007.47 | $0.00 | $0.00 | $0.00 |
| Policy bazooka / monetary euphoria | March 24, 2020 – November 6, 2020 | +160.98% | +368.08% | +$16097.53 | $0.00 | $0.00 | $0.00 |
| Reopening reflation / fiscal boom / supply bottlenecks | November 9, 2020 – November 29, 2021 | -48.05% | -46.27% | $4804.78 | $0.00 | $0.00 | $0.00 |
| Inflation shock / duration crash / aggressive tightening | November 30, 2021 – November 9, 2022 | -59.21% | -61.41% | $5921.06 | $0.00 | $0.00 | $0.00 |
| Disinflation rebound / AI-led narrow bull / higher-for-longer | November 10, 2022 – September 17, 2024 | +189.11% | +77.32% | +$18910.94 | $0.00 | $0.00 | $0.00 |
| Disinflationary easing / resilient growth / AI capex under oil-shock test partial | September 18, 2024 – April 21, 2026 | +2.98% | +1.87% | +$298.34 | $0.00 | $0.00 | $0.00 |
Dividend History
| Date | Per Share | Yield % |
|---|---|---|
| Total | 0 payments |
No dividends recorded.
All calculations use split-adjusted closing prices. Dividends are reinvested on the ex-dividend date at that day's closing price.
For each rolling window, returns are calculated at every possible starting point:
return = (value[i] ÷ value[i − windowSize] − 1) × 100
- Windows
- 1-month = 21 trading days, 1-year = 252 trading days, 3-year = 756 trading days.
- Statistics
- Average: arithmetic mean. Median: middle value when sorted. Best / Worst: max and min. % Positive: share of windows with return > 0.
The series is segmented by calendar year:
return = (endValue ÷ startValue − 1) × 100
startValue is the last value of the prior year (or the first value for the initial year). Partial first/last years are flagged. Dividends, taxes, and transaction costs are scaled proportionally to the initial investment.